Searched for: in-biosketch:true
person:franko02
Risk assessment and stratification for future cardiac events in patients admitted with Acute Coronary Syndrome using a novel critical pathway and its validation by Framingham Risk Score [Meeting Abstract]
Aziz, EF; Bangalore, S; Musat, D; Fawzy, A; Khan, R; Tormey, D; Frankenberger, O; Herzog, E
ISI:000235530401036
ISSN: 0735-1097
CID: 112364
Impact of novel critical care pathway for management of acute coronary syndrome leads to markedly improved compliance with guidelines and decreased angina symptoms at 12-month follow-up [Meeting Abstract]
Aziz, EF; Bangalore, S; Musat, D; Mathew, J; Vargel, S; Coleman, C; Weathers, L; Frankenberger, O; Herzog, E
ISI:000235530401467
ISSN: 0735-1097
CID: 112365
Beta-blockers and amiodarone for the primary prevention of sudden cardiac death
Frankenberger, O; Steinberg, J S
Sudden cardiac death remains a major public health care problem, generally occurring in patients with ventricular dysfunction. Beta-blockers, already of proven benefit for patients after myocardial infarction, have recently been shown to improve functional status and mortality outcomes in patients with heart failure. Amiodarone, a potent antiarrhythmic drug, was recently studied in a number of randomized clinical trials involving patients with heart failure and patients after myocardial infarction. Routine use of amiodarone cannot be recommended in these patient groups, but serious adverse outcomes were not observed. When antiarrhythmic drug therapy is required, amiodarone is the drug of choice for patients with structural heart disease.
PMID: 10980854
ISSN: 1523-3782
CID: 1822762
HLA class II gene expression in human thyroid cells
Badenhoop, K; Fischer, S; Frankenberger, O; Belfiore, A; Buscema, M; Bottazzo, G F; Usadel, K H
PMID: 1281779
ISSN: 0232-7384
CID: 1822772